Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11666638 Glycotargeting therapeutics

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Jun, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Jun, 2023
Edits made to:
Infobox (+76 properties)
Article (+163 characters)
‌

 US Patent 11666638 Glycotargeting therapeutics

Article

Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116666380
Date of Patent
June 6, 2023
0
Patent Application Number
167237740
Date Filed
December 20, 2019
0
Patent Citations
‌
US Patent 7132475 Block copolymers for multifunctional self-assembled systems
0
‌
US Patent 7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
0
‌
US Patent 7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10
0
‌
US Patent 7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
0
‌
US Patent 7285642 Composition and method for modulating dendritic cell-T cell interaction
0
‌
US Patent 7420041 Cytotoxicity mediation of cells evidencing surface expression of TROP-2
0
‌
US Patent 7612180 Humanized L243 antibodies
0
‌
US Patent 7704964 Methods and compounds for the targeting of protein to exosomes
0
‌
US Patent 7884190 Recombinant dimeric and heterodimeric proteins comprising amino acids 193 to 252 of the β chain of the human C4BP protein
0
‌
US Patent 7888460 Diagnostic and therapeutic epitope, and transgenic plant
0
‌
US Patent 7892743 Subtractive single label comparative hybridization
0
‌
US Patent 7932294 Prodrugs containing novel bio-cleavable linkers
0
‌
US Patent 7994283 Dimeric proteins for immunization
0
‌
US Patent 8007805 Chimeric antigens for breaking host tolerance to foreign antigens
0
‌
US Patent 8021689 Nanoparticles for immunotherapy
0
‌
US Patent 8057798 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
0
‌
US Patent 8058400 Composition and method for modulating dendritic cell-t cell interaction
0
‌
US Patent 8105599 Composition and method for modulating dendritic cell-T cell interaction
0
‌
US Patent 8236934 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
0
‌
US Patent 8252902 Antibody targeting compounds
0
‌
US Patent 8273357 Antigen-carbohydrate conjugates
0
‌
US Patent 8318912 Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptide
0
‌
US Patent 8323696 Nanoparticles for immunotherapy
0
‌
US Patent 8329144 Diagnostic and therapeutic epitope, and transgenic plant
0
‌
US Patent 8333973 Targeting recombinant therapeutics to circulating red blood cells
0
‌
US Patent 8343498 Adjuvant incorporation in immunonanotherapeutics
0
‌
US Patent 8449888 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
0
‌
US Patent 8507237 Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives
0
‌
US Patent 8518410 Fusion protein with HIV antigen
0
‌
US Patent 8562998 Targeting of antigen presenting cells with immunonanotherapeutics
0
‌
US Patent 8586052 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
0
‌
US Patent 8592364 CCR7 ligand delivery and co-delivery in immunotherapy
0
‌
US Patent 8617823 Immunomodulating compositions and methods of use thereof
0
‌
US Patent 8637028 Adjuvant incorporation in immunonanotherapeutics
0
‌
US Patent 8673293 Use of modified cells for the treatment of multiple sclerosis
0
‌
US Patent 8685408 Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells
0
‌
US Patent 8722047 Humanized anti-HLA-DR antibodies
0
‌
US Patent 8728481 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
0
‌
US Patent 8859629 Fused cyclooctyne compounds and their use in metal-free click reactions
0
‌
US Patent 8889140 Compositions and methods for tissue repair
0
‌
US Patent 8992917 Humanized L243 antibodies
0
‌
US Patent 9005903 Immunomodulating compositions and methods of use thereof
0
‌
US Patent 9102734 Fusion proteins comprising antibody and HPV E6 and E7 antigens
0
‌
US Patent 9187561 Humanized anti-HLA-DR antibodies
0
‌
US Patent 9216156 Virosome-like vesicles comprising gp41-derived antigens
0
‌
US Patent 9233072 Adjuvant incorporation in immunonanotherapeutics
0
‌
US Patent 9260692 Use of modified cells for the treatment of multiple sclerosis
0
‌
US Patent 9439859 Adjuvant incorporation in immunoanotherapeutics
0
‌
US Patent 9457047 Immunomodulating compositions and methods of use thereof
0
‌
US Patent 9474717 Vaccine nanotechnology
0
‌
US Patent 9517257 Erythrocyte-binding therapeutics
0
‌
US Patent 9518087 Erythrocyte-binding therapeutics
0
‌
US Patent 9522183 Compositions and methods for inducing immune tolerance
0
‌
US Patent 9539210 Vaccine nanotechnology
0
‌
US Patent 9561272 Compositions and methods for modulating immune responses
0
‌
US Patent 9688991 Aptamer-targetted antigen delivery
0
‌
US Patent 9751945 Sortase-modified VHH domains and uses thereof
0
‌
US Patent 9814780 Compositions for inducing antigen-specific tolerance
0
‌
US Patent 9850296 Erythrocyte-binding therapeutics
0
‌
US Patent 9878048 Compositions for generating immune tolerance by targeting erythrocytes
0
‌
US Patent 9901645 Methods for reducing immune responses
0
‌
US Patent 9901646 Methods for induction of antigen-specific immune tolerance
0
‌
US Patent 10046056 Glycotargeting therapeutics
0
‌
US Patent 10800838 Erythrocyte-binding therapeutics
0
‌
US Patent 10821157 Glycotargeting therapeutics
0
‌
US Patent 10919963 Erythrocyte-binding therapeutics
0
‌
US Patent 10940209 Glycotargeting therapeutics
0
‌
US Patent 10946079 Glycotargeting therapeutics
0
‌
US Patent 10953101 Glycotargeting therapeutics
0
Patent Primary Examiner
‌
Thea D'Ambrosio
0

Find more entities like US Patent 11666638 Glycotargeting therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo